ClinicalTrials.gov
ClinicalTrials.gov Menu

The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01655888
Recruitment Status : Unknown
Verified July 2012 by Michele Maio, Azienda Ospedaliera Universitaria Senese.
Recruitment status was:  Recruiting
First Posted : August 2, 2012
Last Update Posted : August 2, 2012
Sponsor:
Collaborator:
MedImmune LLC
Information provided by (Responsible Party):
Michele Maio, Azienda Ospedaliera Universitaria Senese